share_log

永安药业(002365.SZ)发布前三季度业绩,净利润6185.52万元,同比增长33.23%

qianjiang yongan pharmaceutical (002365.SZ) released its performance for the first three quarters, with a net income of 61.8552 million yuan, a year-on-year increase of 33.23%.

Zhitong Finance ·  Oct 29, 2024 16:56

Qianjiang Yongan Pharmaceutical (002365.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...

Zhicheng Finance and Economics APP News, Qianjiang Yongan Pharmaceutical (002365.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.619 billion yuan, a 22.93% year-on-year decrease. Net income attributable to shareholders of the listed company was 61.8552 million yuan, an increase of 33.23% year-on-year. Net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 37.4882 million yuan, an increase of 489.66% year-on-year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment